Literature DB >> 1508608

Selenium and glutathione peroxidase levels in premature infants in a low selenium community (Christchurch, New Zealand).

K B Sluis1, B A Darlow, P M George, N Mogridge, B A Dolamore, C C Winterbourn.   

Abstract

By world standards, the selenium status of the adult population of Christchurch, New Zealand is low. To determine the status of infants undergoing neonatal intensive care, plasma and red cell selenium and glutathione peroxidase levels were measured in infants admitted to the regional neonatal unit. Plasma levels in all newborn infants were one third to one half those in adults. Premature infants had levels significantly lower than those in cord blood from term infants, but their levels were not different from those of term infants admitted to the unit. There were no differences between adult and infant red cell levels. The premature infants remaining in the neonatal unit showed dramatic decreases in plasma selenium and glutathione peroxidase with age, with many infants having selenium levels of less than 0.13 mumol/L (10 micrograms/L). Low levels were seen in infants fed orally as well as those on parenteral nutrition. Thus, the low selenium status of New Zealanders is associated with particularly low selenium levels in premature infants. Because these infants have a high risk for oxidative diseases such as bronchopulmonary dysplasia (chronic lung disease) and retinopathy of prematurity, the possibility that these conditions are more serious in the New Zealand population needs to be assessed and consideration given to dietary supplementation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508608     DOI: 10.1203/00006450-199208000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Randomised clinical trial of parenteral selenium supplementation in preterm infants.

Authors:  L Daniels; R Gibson; K Simmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

Review 2.  Selenium: implications for outcomes in extremely preterm infants.

Authors:  Rachael Tindell; Trent Tipple
Journal:  J Perinatol       Date:  2018-01-03       Impact factor: 2.521

Review 3.  Antioxidants in neonatal lung disease.

Authors:  C H Fardy; M Silverman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

4.  Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant.

Authors:  T E Inder; P Graham; K Sanderson; B J Taylor
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

5.  Selenium Status and Supplementation Effects in Pregnancy-A Study on Mother-Child Pairs from a Single-Center Cohort.

Authors:  Dorota Filipowicz; Ewelina Szczepanek-Parulska; Małgorzata Kłobus; Krzysztof Szymanowski; Thilo Samson Chillon; Sabrina Asaad; Qian Sun; Aniceta A Mikulska-Sauermann; Marta Karaźniewicz-Łada; Franciszek K Główka; Dominika Wietrzyk; Lutz Schomburg; Marek Ruchała
Journal:  Nutrients       Date:  2022-07-27       Impact factor: 6.706

Review 6.  Selenium supplementation to prevent short-term morbidity in preterm neonates.

Authors:  B A Darlow; N C Austin
Journal:  Cochrane Database Syst Rev       Date:  2003

7.  Selenium protects neonates against neurotoxicity from prenatal exposure to manganese.

Authors:  Xin Yang; YiXiao Bao; HuanHuan Fu; LuanLuan Li; TianHong Ren; XiaoDan Yu
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.